Tokyo Tape
Sign in
← Nippon Chemiphar

Quarterly report · Q3

4539.TEDINET S100Q6GP
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥24.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥32.5bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥24.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥192m2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥1.1bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥549m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥1.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥971m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥1.3bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥684m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥700m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥952m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥684m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥952m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥50.0bnat 2022-12-31Cons.Assets
Total assets¥49.5bnat 2022-03-31Cons.Assets
Total assets¥50.6bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥30.9bnat 2022-12-31Cons.Liabilities
Total liabilities¥31.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥19.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥18.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥18.8bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥12.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥11.6bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥189.622022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-58.822022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥194.332021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥264.152021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥200.362021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio38.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥719m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥719m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥21m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥9m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥9m
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥23.3bn
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥23.3bn
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E00957-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥170m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥24.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥24.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥192m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥742m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥722m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥20m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥41m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥30m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥30m
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue2021-04-01 → 2021-12-31¥24.0bn
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue external2021-04-01 → 2021-12-31¥24.0bn
jpcrp040300-q3r_E00957-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥10m
jpcrp040300-q3r_E00957-000Medicinereportable segmentsegment profit2021-04-01 → 2021-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥24.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥24.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥30m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 417
ItemContextValueUnit
Other clPrior1YearInstant913000000JPY
Other clCurrentQuarterInstant389000000JPY
Current liabilitiesPrior1YearInstant16750000000JPY
Current liabilitiesCurrentQuarterInstant15381000000JPY
Long term loans payablePrior1YearInstant11399000000JPY
Long term loans payableCurrentQuarterInstant12172000000JPY
Lease obligations nclPrior1YearInstant135000000JPY
Lease obligations nclCurrentQuarterInstant156000000JPY
Provision for directors retirement benefitsPrior1YearInstant469000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant451000000JPY
Net defined benefit liabilityPrior1YearInstant132000000JPY
Net defined benefit liabilityCurrentQuarterInstant141000000JPY
Deferred tax liabilities for land revaluationPrior1YearInstant915000000JPY
Deferred tax liabilities for land revaluationCurrentQuarterInstant915000000JPY
Other nclPrior1YearInstant1149000000JPY
Other nclCurrentQuarterInstant1645000000JPY
Noncurrent liabilitiesPrior1YearInstant14202000000JPY
Noncurrent liabilitiesCurrentQuarterInstant15482000000JPY
LiabilitiesPrior1YearInstant30952000000JPY
LiabilitiesCurrentQuarterInstant30864000000JPY
Capital stockPrior1YearInstant4304000000JPY
Capital stockCurrentQuarterInstant4304000000JPY
Capital surplusPrior1YearInstant1263000000JPY
Capital surplusCurrentQuarterInstant1263000000JPY
Retained earningsPrior1YearInstant13482000000JPY
Retained earningsCurrentQuarterInstant13981000000JPY
Treasury stockPrior1YearInstant-3110000000JPY
Treasury stockCurrentQuarterInstant-3110000000JPY
Shareholders equityPrior1YearInstant15939000000JPY
Shareholders equityCurrentQuarterInstant16438000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant547000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant322000000JPY
Revaluation reserve for landPrior1YearInstant2070000000JPY
Revaluation reserve for landCurrentQuarterInstant2072000000JPY
Foreign currency translation adjustmentPrior1YearInstant-170000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant235000000JPY
Remeasurements of defined benefit plansPrior1YearInstant98000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant85000000JPY
Valuation and translation adjustmentsPrior1YearInstant2545000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant2715000000JPY
Subscription rights to sharesPrior1YearInstant17000000JPY
Subscription rights to sharesCurrentQuarterInstant17000000JPY
Net assetsPrior1YearInstant18501000000JPY
Net assetsCurrentQuarterInstant19171000000JPY
Liabilities and net assetsPrior1YearInstant49453000000JPY
Liabilities and net assetsCurrentQuarterInstant50035000000JPY
Net salesPrior1YTDDuration24727000000JPY
Net salesCurrentYTDDuration24015000000JPY
Cost of salesPrior1YTDDuration17642000000JPY
Cost of salesCurrentYTDDuration17665000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass